Dr. Rupali Paranjape
Ph.D. (Chemistry, Pharmaceutical Analysis - Formulation)
Founder, Blue Ocean of Compliance
International Best Selling Author
Asia's 1st "Blue Ocean Compliance" Mentor
Global Icon of Pharma Compliance
Asia's Award winning Global Pharma Leader
Regulatory and Compliance Consultant Auditor and Trainer for Pharmaceutical Companies
ISO 9001:2015 Lead Auditor QMS
  • About
  • Audit & Compliance
  • Regulatory
  • Training
  • Blog
  • Contact
  • The Book

Blog

Blue Paper Indian Fashion Sale Instagram Post 5

Jun 26, 2022

Are you violating 21 CFR 211.160(b) ?
Blue Paper Indian Fashion Sale Instagram Post 4

Jun 23, 2022

Violation of "Subpart D - Equipment-211.67 Equipment cleaning and maintenance."
Express Pharma 2

Jun 20, 2022

Express Pharma India's Foremost Pharma & Biotech Magazine- Received the Physical Copy an amazing experience.
Blue Paper Indian Fashion Sale Instagram Post 3

Jun 14, 2022

There are companies who qualify the audit with no observation and there are companies who got warning letters. Why?
People r bulding blocks

Jun 07, 2022

A company is the collective mind of the people working in that company.
Do not prepare for audit

Jun 06, 2022

Do not prepare for the audit
Blue Paper Indian Fashion Sale Instagram Post 6

Jun 05, 2022

Many times root cause of the problem is different than what we think.
Blue Ocean Photo Summer Instagram Post

Jun 01, 2022

Warning Letter observation discussion series- Sr. No. 3
Valentines Sale Banner Landscape 1

May 28, 2022

WARNING LETTER OBSERVATION DISCUSSION SERIES- SR. NO. 2
Valentines Sale Banner Landscape

May 27, 2022

Warning Letter observation discussion series- Sr. No. 1
Blue Paper Indian Fashion Sale Instagram Post 4

May 25, 2022

Warning Letter Discussion- 621313 - Part 3
Interview on Indian Pharma Post

May 24, 2022

Read my interview on Indian Pharma Post with Mr. Thomas C Thottathil
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next
© 2025 Dr. Rupali Paranjape